SD-8, a novel therapeutic agent active against multidrug-resistant Gram positive cocci

Amino Acids

Volumn 39, Issue 5, 2010, Pages 1493-1505

  Mishra, Biswajit ^a   Srivastava, Vipul Kumar ^a   Chaudhry, Rama ^a   Somvanshi, Rishi Kumar ^a   Singh, Abhay Kumar ^a   Gill, Kamaldeep ^a   Somvanshi, Ramesh ^b   Patro, Ishan Kumar ^c   Dey, Sharmistha ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^c JIWAJI UNIVERSITY   (India)

Author keywords

Anti inflammatory; Antimicrobial peptides; Cyclooxygenase; Histopathology; Multidrug resistant; Surface plasmon resonance

Indexed keywords

ARGINYLLEUCYLLYSYLLEUCYLLEUCYLARGINYLLEUCINE AMIDE; ARGINYLLEUCYLLYSYLLEUCYLLEUCYLLEUCYLARGINYLLEUCINE AMIDE; ARGINYLLEUCYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLARGINYLLEUCINE AMIDE; ARGINYLLEUCYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLLEUCYLARGINYLLEUCINE AMIDE; ARGINYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLLEUCYLALANYLARGINYLTRYPTOPHAN AMIDE; ARGINYLTRYPTOPHANYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLLEUCYLALANYLALANINE AMIDE; ARGINYLTRYPTOPHANYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLLEUCYLALANYLLEUCINE AMIDE; ARGINYLTRYPTOPHANYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLLEUCYLALANYLVALINE AMIDE; ARGINYLTRYPTOPHANYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLLEUCYLLEUCINE AMIDE; CYCLOOXYGENASE 2; DICLOFENAC; GENTAMICIN; LEUCYLARGINYLLYSYLLEUCYLLEUCYLLEUCYLLEUCYLLEUCYLARGINYLLEUCINE AMIDE; NIMESULIDE; PEPTIDE SD 8; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; ENTEROCOCCUS; ENZYME INHIBITION; HEMOLYSIS; HISTOPATHOLOGY; MEMBRANE PERMEABILITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; MICROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, MULTIPLE; GRAM-POSITIVE COCCI; HEMOLYSIS; HUMANS; KINETICS; MICROBIAL SENSITIVITY TESTS; PEPTIDES; RATS; RATS, WISTAR; SKIN; SOLUBILITY; SURFACE PLASMON RESONANCE;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; RATTUS; STAPHYLOCOCCUS AUREUS;

EID: 78449311798     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-010-0618-z     Document Type: Article

References (48)

1. J Alvarez-Bravo S Kurata S Natori 1994 Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus Biochem J 302 535 538 1:CAS:528:DyaK2MXltFantQ%3D%3D 8093007
2. D Andreu L Rivas 1998 Animal antimicrobial peptides: an overview Biopolymers 47 415 433 1:CAS:528:DyaK1MXjtFSmsLc%3D 10.1002/(SICI)1097- 0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D 10333735
3. D Andreu J Ubach A Boman B Wahlin D Wade RB Merrifield HG Boman 1992 Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity FEBS Lett 296 190 194 1:CAS:528:DyaK38Xht1Cktrk%3D 10.1016/0014-5793(92)80377-S 1733777
4. GS Bisht DS Rawat A Kumar R Kumar S Pasha 2007 Antimicrobial activity of rationally designed amino terminal modified peptides Bioorg Med Chem Lett 17 4343 4346 1:CAS:528:DC%2BD2sXnsVKms7o%3D 10.1016/j.bmcl.2007.05.015 17553680
5. Y Chen CT Mant SW Farmer RE Hancock ML Vasil RS Hodges 2005 Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index J Biol Chem 280 12316 12329 1:CAS:528: DC%2BD2MXislyht7k%3D 10.1074/jbc.M413406200 15677462
6. Y Chen MT Guarnieri AI Vasil ML Vasil CT Mant RS Hodges 2007 Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides Antimicrob Agents Chemother 51 1398 1406 1:CAS:528: DC%2BD2sXktlOjtLY%3D 10.1128/AAC.00925-06 17158938
7. B Christensen J Fink RB Merrifield D Mauzerall 1998 Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes Proc Natl Acad Sci USA 85 5072 5076 10.1073/pnas.85.14.5072
8. O Cirioni C Silvestri R Ghiselli A Giacometti F Orlando F Mocchegiani L Chiodi AD Vittoria V Saba G Scalise 2006 Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides Peptides 27 2600 2606 1:CAS:528:DC%2BD28XhtFSrtrjO 10.1016/j.peptides.2006.05.004 16797106
9. O Cirioni A Giacometti W Kamysz C Silvestri A Riva A Della Vittoria A Abbruzzetti J Lukasiak G Scalise 2007 In vitro activities of tachyplesin III against Pseudomonas aeruginosa Peptides 28 747 751 1:CAS:528: DC%2BD2sXislGqsbs%3D 10.1016/j.peptides.2007.01.001 17331619
10. Culling CFA (1995) Handbook of histological techniques, 2nd edn. Butterworth & Co, London
11. DA Devine RE Hancock 2002 Cationic peptides: distribution and mechanisms of resistance Curr Pharm Des 8 703 714 1:CAS:528:DC%2BD38XjtlWktr4%3D 10.2174/1381612023395501 11945166
12. H Duclohier G Molle G Spach 1989 Antimicrobial peptide magainin I from Xenopus skin forms anion-permeable channels in planar lipid bilayers Biophys J 56 1017 1021 1:CAS:528:DyaK3cXhvFM%3D 10.1016/S0006-3495(89)82746-8 2481510
13. V Frecer B Ho JL Ding 2004 De novo design of potent antimicrobial peptides Antimicrob Agents Chemother 48 3349 3357 1:CAS:528:DC%2BD2cXnsVehsrw%3D 10.1128/AAC.48.9.3349-3357.2004 15328096
14. CL Friedrich D Moyles TJ Beveridge RE Hancock 2000 Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria Antimicrob Agents Chemother 44 2086 2092 1:CAS:528:DC%2BD3cXltlShsLw%3D 10.1128/AAC.44.8.2086-2092.2000 10898680
15. R Gadepalli B Dhawan V Sreenivas A Kapil AC Ammini R Chaudhry 2006 A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital Diabetes Care 29 1727 1732 10.2337/dc06-0116 16873771
16. A Giacometti O Cirioni W Kamysz G D'Amato C Silvestri MS Del Prete A Licci A Riva J Lukasiak G Scalise 2005 In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients Antimicrob Agents Chemother 49 1249 1252 1:CAS:528:DC%2BD2MXit12lsL4%3D 10.1128/AAC.49.3.1249-1252.2005 15728942
17. JK Gierse CM Koboldt MC Walker K Seibert PC Isakson 1999 Kinetic basis for selective inhibition of cyclo-oxygenases Biochem J 339 607 614 1:CAS:528:DyaK1MXksFKrsLs%3D 10.1042/0264-6021:3390607 10215599
18. Hancock RWE MIC determination for cationic antimicrobial peptide by modified micro titer broth dilution method. Hancock laboratory. http://cmdr.ubc.ca/bobh/methods/methodsall.html )
19. RE Hancock 1997 Peptide antibiotics Lancet 349 418 422 1:CAS:528:DyaK2sXhvVamur0%3D 10.1016/S0140-6736(97)80051-7 9033483
20. RE Hancock DS Chapple 1999 Peptide antibiotics Antimicrob Agents Chemother 43 1317 1323 1:CAS:528:DyaK1MXjs12nsrc%3D 10348745
21. RE Hancock R Lehrer 1998 Cationic peptides: a new source of antibiotics Trends Biotechnol 16 82 88 1:CAS:528:DyaK1cXht1Snsrg%3D 10.1016/S0167-7799(97) 01156-6 9487736
22. RE Hancock HG Sahl 2006 Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat Biotechnol 24 1551 1557 1:CAS:528:DC%2BD28Xht12gtbvM 10.1038/nbt1267 17160061
23. A Jasir F Kasprzykowski R Kasprzykowska V Lindstrom C Schalen A Grubb 2003 New antimicrobial cystatin C-based peptide active against Gram-positive bacterial pathogens, including methicillin-resistant Staphylococcus aureus and multiresistant coagulase-negative staphylococci APMIS 111 1004 1010 1:CAS:528:DC%2BD2cXivVanug%3D%3D 10.1111/j.1600-0463.2003.t01-1-apm1111102.x 14629266
24. RN Jones 2006 Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains Clin Infect Dis 42 13 24 10.1086/491710
25. E Klein DL Smith R Laxminarayan 2007 Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005 Emerg Infect Dis 13 1840 1846 18258033
26. E Kretschmann H Reather 1968 Radiative decay of nonradiative surface plasmon excited by light Z Naturf A 23 2135 2136 1:CAS:528:DyaF1MXhtVWgtr0%3D
27. Mackie TJ, McCartney JE (1996) Mackie & McCartney practical medical microbiology, 14th edn. Churchill Livingstone, New York
28. P Mathur NR Jagannathan VS Chauhan 2007 Alpha, beta-dehydrophenylalanine containing cecropin-melittin hybrid peptides: conformation and activity J Pept Sci 13 253 262 1:CAS:528:DC%2BD2sXks1Ojtbo%3D 10.1002/psc.841 17394119
29. JE McInturff SJ Wang T Machleidt TR Lin A Oren CJ Hertz SR Krutzik S Hart K Zeh DH Anderson 2005 Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes J Invest Dermatol 125 256 263 1:CAS:528:DC%2BD2MXntlCrt7g%3D 10.1111/j.0022-202X.2004.23459.x 16098035
30. RB Merrifield 1963 Solid phase peptide synthesis. I. The synthesis of a tetrapeptide J Am Chem Soc 85 2149 2154 1:CAS:528:DyaF3sXksVajsLg%3D 10.1021/ja00897a025
31. J Nissen-Meyer IF Nes 1997 Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action Arch Microbiol 167 67 77 1:CAS:528:DyaK2sXhvFOqurs%3D 10.1007/s002030050418
32. C Nylander B Leidberg T Lind 1982 Gas detection by means of surface plasmon resonance Sens Actuators 3 79 88 1:CAS:528:DyaL3sXot12itw%3D%3D 10.1016/0250-6874(82)80008-5
33. Z Oren Y Shai 1998 Mode of action of linear amphipathic alpha-helical antimicrobial peptides Biopolymers 47 451 463 1:CAS:528:DyaK1MXjtFSmsb8%3D 10.1002/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F 10333737
34. A Otto 1968 Excitation of nonradiative surface plasma waves in silver by the method of frustrated total reflection Z Phys 216 398 410 1:CAS:528:DyaF1MXhsFaisg%3D%3D 10.1007/BF01391532
35. JA Richards TA Petrel RW Brueggemeier 2002 Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells J Steroid Biochem Mol Biol 80 203 212 1:CAS:528:DC%2BD38XhvVCitbc%3D 10.1016/S0960- 0760(01)00187-X 11897504
36. HS Sader AA Watters TR Fritsche RN Jones 2007 Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005) BMC Infect Dis 7 29 10.1186/1471-2334-7-29 17442104
37. G Sakoulas PA Moise-Broder J Schentag A Forrest RC Moellering Jr GM Eliopoulos 2004 Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia J Clin Microbiol 42 2398 2402 1:CAS:528:DC%2BD2cXlslamtLY%3D 10.1128/JCM.42.6.2398-2402.2004 15184410
38. JJ Schentag JM Hyatt JR Carr JA Paladino MC Birmingham GS Zimmer TJ Cumbo 1998 Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control Clin Infect Dis 26 1204 1214 1:CAS:528:DyaK1cXjt1Oqtb0%3D 10.1086/520287 9597254
39. U Schwab P Gilligan J Jaynes D Henke 1999 In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens Antimicrob Agents Chemother 43 1435 1440 1:CAS:528:DyaK1MXjs12nsb4%3D 10348766
40. T Sigurdardottir P Andersson M Davoudi M Malmsten A Schmidtchen M Bodelsson 2006 In silico dentification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37 Antimicrob Agents Chemother 50 2983 2989 1:CAS:528:DC%2BD28XpsFenurc%3D 10.1128/AAC.01583-05 16940092
41. N Sitaram KP Sai S Singh K Sankaran R Nagaraj 2002 Structure-function relationship studies on the frog skin antimicrobial peptide tigerinin 1: design of analogs with improved activity and their action on clinical bacterial isolates Antimicrob Agents Chemother 46 2279 2283 1:CAS:528:DC%2BD38XltVWms7w%3D 10.1128/AAC.46.7.2279-2283.2002 12069990
42. RK Somvanshi A Kumar S Kant D Gupta SB Singh U Das A Shrinivashan TP Singh S Dey 2007 Surface plasmon studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent Biochem Biophy Res Commun 361 37 42 1:CAS:528:DC%2BD2sXotlWrurc%3D 10.1016/j.bbrc.2007. 06.122
43. van't Hof W, Veerman EC, Helmerhorst EJ, Amerongen AV (2001) Antimicrobial peptides: properties and applicability. Biol Chem 382:597-619
44. K Yamada S Natori 1994 Characterization of the antimicrobial peptide derived from sapecin B, an antibacterial protein of Sarcophaga peregrina (flesh fly) Biochem J 298 623 628 1:CAS:528:DyaK2cXivFagtL0%3D 8141776
45. M Zaitsu Y Hamasaki M Matsuo M Miyazaki R Hayasaki E Muro S Yamamoto I Kobayashi T Ichimaru S Miyazaki 1999 Induction of cytosolic phospholipase A2 and prostaglandin H2 synthase-2 by lipopolysaccharide in human polymorphonuclear leukocytes Eur J Haematol 63 94 102 1:CAS:528:DyaK1MXmsFClsLw%3D 10.1111/j.1600-0609.1999.tb01122.x 10480288
46. M Zasloff 1987 Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor Proc Natl Acad Sci USA 84 5449 5453 1:CAS:528: DyaL1cXhsl2ntw%3D%3D 10.1073/pnas.84.15.5449 3299384
47. L Zhang J Parente SM Harris DE Woods RE Hancock TJ Falla 2005 Antimicrobial peptide therapeutics for cystic fibrosis Antimicrob Agents Chemother 49 2921 2927 1:CAS:528:DC%2BD2MXlvFSlsL0%3D 10.1128/AAC.49.7.2921- 2927.2005 15980369
48. WL Zhu H Lan IS Park JI Kim HZ Jin KS Hahm SY Shin 2006 Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1 Biochem Biophys Res Commun 349 769 774 1:CAS:528:DC%2BD28Xps1Ogtrg%3D 10.1016/j.bbrc.2006.08.094 16945333